Gabrail Cancer Center Launches Study of Elranatamab and Low-Dose Lenalidomide Combination
The Gabrail Cancer Center Undertakes Investigator-Initiated Study Evaluating the T-Cell Engager Elranatamab in Combination with Starton Therapeutics’ Controlled Low-Dose Lenalidomide The Gabrail Cancer and Research Center, a PhaseWell Research site, announced that Nashat Gabrail, M.D., has received notification from the…
Naturmega to Debut SUPRIAX2™ Solution in North America at SupplySide Global 2026
Naturmega’s SUPRIAX2™ Solution to Make Its North American Debut at SupplySide Global 2026 Naturmega, an advanced lipid science company specializing in omega-3 and next-generation lipid technologies, will introduce SUPRIAX2™ to the North American market at SupplySide Global 2026 in Las…
GE HealthCare’s Photonova™ Spectra Receives CE Mark, Expanding Global Access
GE HealthCare’s Photonova™ Spectra gains CE Mark, expanding international access GE HealthCare recently achieved CE Mark for Photonova Spectra,i an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon™ detector technology. The regulatory milestone expands access and enables…
Yangi Brings Cellera® Dry-Forming Technology to U.S. Converters Amid Tariff Changes
As Tariffs Reshape the Molded Fiber Market, Yangi Brings Its Dry-Forming Technology Cellera® to U.S. Converters Yangi, the Swedish developer of Cellera®, a dry-forming technology for fiber-based packaging, is entering the U.S. market with its quick-serve packaging range, as part of…
PPG Introduces ONE RANGE Solutions for Onboard Maintenance
PPG introduces PPG ONE RANGE portfolio for onboard maintenance PPG announced the launch of the PPG ONE RANGE™ portfolio of five one-component marine coatings at the SMM 2026 maritime industry trade fair in Hamburg, Germany. Designed to simplify onboard fleet…
Erthwrks Strengthens Environmental Platform with Strategic Acquisition of Arktos Environmental
Erthwrks Expands Platform with Strategic Acquisition of Arktos Environmental Erthwrks, LLC a leading environmental compliance services company, announced the acquisition of Arktos Environmental (“Arktos”), a premier provider of Optical Gas Imaging (OGI) and Leak Detection and Repair (LDAR) services. The acquisition…
Agenus Reports Promising NEST Phase 2 Results Showing Deep Pathologic Responses in Resectable Colon Cancer
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer Agenus , a leader in immuno-oncology innovation, today announced the peer-reviewed publication of updated results from the investigator-sponsored Phase…
Magnolia Advanced Materials Unveils Complete Advanced Materials Suite for eVTOL Manufacturers
Magnolia Advanced Materials Launches Complete Advanced Materials Product Suite for eVTOL Manufacturers Magnolia Advanced Materials, Inc., a custom formulator of high-performance epoxy systems for aerospace, defense and industrial applications, today announced that its recently formed Research and Development (R&D) team…
Komodo Health and NCQA Partner to Advance Healthcare Quality Measurement
Komodo Health and NCQA Collaborate to Accelerate the Future of Healthcare Quality Measurement Komodo Health®, an AI-powered healthcare intelligence company, announced a multi-year strategic effort with the National Committee for Quality Assurance (NCQA) to modernize how healthcare quality measures are…
New Neurology Study Strengthens Evidence for Quantitative MRI Biomarkers in SBMA
Measuring Muscles with Quantitative MRI: New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA AMRA Medical is pleased to announce the publication of new research in Neurology demonstrating the potential of quantitative whole-body MRI to measure disease progression…
Hyperfine Marks First Year of Neurology Office Launch with NEURO PMR Publication and Over 3,000 Scans
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans Hyperfine, Inc. the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for…
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing high-quality, cost-effective animal health products, today announced the U.S. launch of Robenacoxib Injection, the only FDA-approved bioequivalent to ONSIOR® (robenacoxib)…